NORTHWEST BIOTHERAPEUTICS INC (NWBO) Executive Compensation
NORTHWEST BIOTHERAPEUTICS INC (NWBO) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NWBO
CIK: 1072379
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMatthew Dobbins
Audit LocationNashville, Tennessee, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097188 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-29 | FORM 8-K | 0001104659-26-089293 | View SEC Doc Filr Page |
| 424B5 | 2026-07-31 | — | 424B5 | 0001104659-26-089290 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-17 | FORM 8-K | 0001104659-26-084743 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062661 | View SEC Doc Filr Page |
| EFFECT | 2026-04-20 | — | EFFECT Filing | 9999999995-26-001251 | View SEC Doc Filr Page |
| POS AM | 2026-04-16 | — | POS AM | 0001104659-26-044463 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001104659-26-043806 | View SEC Doc Filr Page |
| 8-K | 2026-04-07 | 2025-10-24 | FORM 8-K | 0001104659-26-040260 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001104659-26-037871 | View SEC Doc Filr Page |
| 8-K | 2026-01-15 | 2026-01-15 | FORM 8-K | 0001104659-26-004146 | View SEC Doc Filr Page |
| 8-K | 2026-01-02 | 2025-12-29 | FORM 8-K | 0001104659-26-000243 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-28 | 2025-12-29 | FORM DEF 14A | 0001104659-25-116966 | View SEC Doc Filr Page |
| EFFECT | 2025-11-25 | — | EFFECT Filing | 9999999995-25-003389 | View SEC Doc Filr Page |
| 424B5 | 2025-11-25 | — | 424B5 | 0001104659-25-116045 | View SEC Doc Filr Page |
| CORRESP | 2025-11-24 | — | CORRESP Filing | 0001104659-25-115479 | View SEC Doc Filr Page |
| 8-K | 2025-11-20 | 2025-11-14 | FORM 8-K | 0001104659-25-114627 | View SEC Doc Filr Page |
| PRE 14A | 2025-11-19 | 2025-12-29 | FORM PRE 14A | 0001104659-25-114107 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001104659-25-112676 | View SEC Doc Filr Page |
| 8-K | 2025-10-31 | 2025-10-27 | FORM 8-K | 0001104659-25-104812 | View SEC Doc Filr Page |
| 8-K | 2025-10-30 | 2025-10-24 | FORM 8-K | 0001104659-25-104427 | View SEC Doc Filr Page |
| 8-K | 2025-10-24 | 2025-10-23 | FORM 8-K | 0001104659-25-102049 | View SEC Doc Filr Page |
| S-3 | 2025-10-24 | — | FORM S-3 | 0001104659-25-101916 | View SEC Doc Filr Page |
| 8-K | 2025-10-14 | 2025-10-09 | FORM 8-K | 0001104659-25-099196 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001410578-25-001825 | View SEC Doc Filr Page |